Illuma Labs Secures $9 Million in Series A Funding to Enhance Voice Authentication and Combat Fraud

Illuma Labs, a pioneering force in voice authentication technology for banking institutions, has successfully closed a $9 million Series A funding round. The investment, led by LiveOak Ventures and supported by Forefront Venture Partners, Curql Fund, UsNet, Capital Factory, Connexus, and TDECU, will drive the company’s efforts to develop cutting-edge solutions to tackle fraud, voice…

Read More

Eric Stonestrom Appointed as Board Chair of Cox Science Center and Aquarium

The Cox Science Center and Aquarium (CSCA) proudly announces the appointment of Eric Stonestrom as its new Board Chair, effective immediately following the retirement of Lew Crampton. Stonestrom, a distinguished technology executive with a deep-rooted passion for sciences, brings over 40 years of expertise in telecommunications to his new role. “Eric’s appointment marks an exciting…

Read More

Raft Capital Management Launches €50M Fund to Boost Baltic and Nordic Business Growth

In a strategic move aimed at fueling regional growth and innovation, Raft Capital Management has unveiled its latest €50 million investment fund. This initiative by the Vilnius-based venture capital firm is set to empower burgeoning businesses across the Baltic States, while also eyeing opportunities in the Nordic countries and Poland. Raft Capital, known for its…

Read More

Hyro Raises $45 M to Cement AI Agents as the New Frontline in Healthcare Access

Hyro, a conversational‑AI platform built for healthcare enterprises, has announced a $45 million strategic growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, and strategic investors including Bon Secours Mercy Health and ServiceNow Ventures. The financing comes just ten months after Hyro’s previous raise and brings its total funding to approximately $95 million. Co‑founded by…

Read More
Bogdan Nesvit and Anatolii Kasianov, Co-Founders and Co-CEOs of HOLYWATER

The “Netflix of Verticals”: HOLYWATER Secures Record $22M to Reshape Global Entertainment

In a definitive move that signals the arrival of “mobile-first” cinema in the West, HOLYWATER has announced a landmark $22 million financing round. This capital injection represents the largest confirmed investment in the microdrama sector outside of Asia, positioning the Kyiv and Lisbon-based tech pioneer as the undisputed leader in an industry currently valued at…

Read More

The $15M Raise Defining a New Category: How Raindrop Is Building the Safety Layer AI Agents Can’t Operate Without

In a landscape where AI agents are becoming autonomous operators rather than passive tools, Raindrop has secured $15 million in seed financing, a raise that signals one thing clearly: observability for AI agents is no longer optional—it is a new infrastructure layer. The round was led by Lightspeed Venture Partners, with participation from several frontier…

Read More

Pioneering Pet Wellness: Tandem Secures $10M to Transform Veterinary Care with AI Innovation

In a bold stride toward reimagining pet healthcare, Cambridge, Massachusetts-based startup Tandem has clinched $10 million in pre-seed funding, announced today, to elevate veterinary services into a seamless, technology-driven experience. This visionary company, already making waves with its mobile clinics and telemedicine offerings, is set to unveil a 5,000-square-foot, AI-powered health hub this summer—an emblem…

Read More

AIRS Medical Secures $20M in Series C Funding to Expand AI-Powered Healthcare Solutions

AIRS Medical, a trailblazer in artificial intelligence (AI) and robotics for healthcare applications, has announced a significant milestone with the closing of its Series C funding round, securing $20 million from leading institutional investors in South Korea. BSK Investment and Shinyoung Securities led the investment, underscoring confidence in AIRS Medical’s pioneering efforts to revolutionize preventive…

Read More

Summit Therapeutics Raises $500 Million in Private Placement to Propel Ivonescimab’s Clinical Advancement and Solidify Leadership in Next-Gen Oncology

In a significant capital infusion, Summit Therapeutics Inc., a Miami-headquartered biopharmaceutical company specializing in oncology, has successfully raised $500 million through a private placement of approximately 26.68 million common shares priced at $18.74 each—the closing price on October 21, 2025. The offering was led by a blend of institutional biotech investors and company insiders, signaling…

Read More